Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.
D000328:Adult; D000595:Amino Acid Sequence; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood*; D002163:Cameroon; D016022:Case-Control Studies; D002809:Chondroitin Sulfates / Q000378:metabolism; D004912:Erythrocytes / Q000469:parasitology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D017780:Malaria Vaccines / Q000276:immunology; D016778:Malaria, Falciparum / Q000150:complications* / Q000276:immunology* / Q000469:parasitology; D020066:Merozoite Surface Protein 1 / Q000235:genetics / Q000378:metabolism; D008969:Molecular Sequence Data; D010920:Placenta / Q000469:parasitology*; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000276:immunology* / Q000469:parasitology
D000913:Antibodies, Protozoan; D017780:Malaria Vaccines; D020066:Merozoite Surface Protein 1; D002809:Chondroitin Sulfates